Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-037311

Chief Legal Officer sold 5,000 shares at $20.00 ($100,000)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-11 Sale : show line 1 in the form −100 $20.00 $2,000 82,536 D
2018-06-12 Sale : show line 2 in the form −4,900 $20.00 $98,000 77,636 D
Open-market sales · 5,000 sh · avg $20.00 · $100,000
Loading xslF345X03/doc4.xml…